FindTrial
Sign In

A Clinical trial to study the effects of two techniques-using patients own blood and fibrin glue-for conjunctival graft adherence in pterygium surgery

A Prospective Randomised Controlled Trial to compare the efficacy and outcome of Autologous blood and Fibrin glue for conjunctival autograft adherence in Sutureless Pterygium surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2013/06/003764
Enrollment
200
Registered
2013-06-18
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Clinically Significant Primary Pterygium Health Condition 2: H110- Pterygium of eye

Interventions

Intervention1: Excision Pterygium with Free Conjunctival Autograft with Autologous blood: Patients own blood at the surgical site is used for adherence of the conjunctival autograft to the bare sclera

Sponsors

Dr Abraham Kurian
Lead Sponsor
Dr Iodine Reghunadhan
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: Clinically significant primary pterygia

Exclusion criteria

Exclusion criteria: 1)Recurrent Pterygium 2)Patients with significant ocular surface disease 3)Patients with known hypersensitivity to fibrin glue or any of its components 4)Patients on Anticoagulants or antirheological agents (as these are thought to have an adverse effect on the adherence of the graft with autologous blood)

Design outcomes

Primary

MeasureTime frame
1)Graft adherence 2)RecurrenceTimepoint: 1)1 day,1 week 2)1 year—

Secondary

MeasureTime frame
Complications like Graft retraction,Subconjunctival haemorrhageTimepoint: 1 day,1 week,1month—

Countries

India

Contacts

Public ContactDr Iodine Reghunadhan

Chaithanya Eye Hospital and Research Institute

iodine_b@yahoo.com919847104830

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Mar 7, 2026